Results 81 to 90 of about 187,398 (301)

Prevalence, predictors and prognostic implications of PR interval prolongation in patients with heart failure [PDF]

, 2017
Aims: To determine the prevalence, incidence, predictors and prognostic implications of PR interval prolongation in patients referred with suspected heart failure.
AL Aro, AL Clark, Andrew L. Clark, AS Levey, B Olshansky, CS Kwok, DJ Friedman, EZ Soliman, F Holmqvist, HC Bazett, JB Nielsen, JM Moser, John G. Cleland, Jufen Zhang, K Schumacher, Kevin M. Goode, L Januszkiewicz, LA Pires, LH Ling, M Cheng, M Stockburger, MB Kronborg, P Sanders, PE Bloch Thomsen, Pierpaolo Pellicori, R Gervais, R Sandhu, RK Crisel, S Baldasseroni, S Cheng, SJ Park, Syed Kazmi, T Nikolaidou, T Nikolaidou, Theodora Nikolaidou, V Kutyifa   +35 more
core   +5 more sources

Prevalence and Long‐Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Heart failure (HF) with reduced ejection fraction (rEF) is a widely regarded prognosticator after coronary artery bypass grafting. HF with preserved ejection fraction (pEF) accounts for up to half of all HF cases and is associated with ...
Louise Y. Sun, Jack V. Tu, Anan Bader Eddeen, Peter P. Liu   +3 more
doaj   +1 more source

Cold Atmospheric Plasma‐Activated Decellularized Extracellular Matrix Gel as a Tumor‐Infiltrating Immunoactivation Platform for Post‐Surgical Cancer Immunotherapy

Advanced Materials, EarlyView.
An injectable cold atmospheric plasma‐activated decellularized tumor extracellular matrix hydrogel is introduced as a post‐surgical immunoactivation platform. The engineered gel attracts residual tumor cells and induces immunogenic cell death, reshaping the tumor microenvironment and eliciting systemic antitumor immunity. In combination with checkpoint
Tianxu Fang, Mo Chen, Yueyang Deng, Tianqin Ning, Tianwen Luo, Guojun Chen   +5 more
wiley   +1 more source

A Nano‐Interception Strategy for Chronic Heart Failure: Prussian Blue Nanoparticles Disrupt Fibroblast‐Immune Communication via CCL2 Sequestration

Advanced Materials, EarlyView.
A nano‐interception strategy disrupts pathogenic fibroblast–macrophage crosstalk in chronic heart failure. Scalable Prussian blue nanoparticles selectively sequester CCL2 via ultrahigh‐affinity binding, preventing CCR2+ macrophage recruitment and breaking a key fibro‐inflammatory circuit. This approach demonstrates robust efficacy in murine and porcine
Bo Chen, Gao Wei, Guowei Zeng, Haoyu Li, Rongrong Wu, Hongyu Yan, Zijie Zhou, Kai Luo, Xiaoyang Zhang, Cong Li, Longming Huang, Lingyan Cheng, Xinjie Zhang, Jinghao Zheng, Bozhong Shi, Xiaojun Cai, Xiaomin He   +16 more
wiley   +1 more source

Recent Advances in Electrospun Nanofibers for Triboelectric Nanogenerators: Performance Enhancement Strategies and Emerging Applications

Advanced Materials, EarlyView.
This review highlights recent advances in electrospun nanofiber‐based triboelectric nanogenerators, emphasizing how material design, fiber architecture, and interface engineering collectively enhance output performance and mechanical durability. Key developments in porous, aligned, core‐shell, and hierarchical nanofibers are discussed alongside ...
MD Fajla Rabbi, Jee Hwan Ahn, Duy Linh Vu, Kyoung Kwan Ahn   +3 more
wiley   +1 more source

Levels of Galectin-3, Advanced Glycated End-Products in Serum, Endothelial Function and Cardiac Hemodynamics in Post Infarction Heart Failure in Patients with Reduced and Preserved Ejection Fraction [PDF]

, 2018
Epidemiological studies have reported that the rate of signs and symptoms of heart failure after myocardial infarction is approximately 25%. In addition, approximately 40% of myocardial infarctions are accompanied by left ventricular systolic ...
Kuryata, O., Sirenko, O., Zabida, A.
core  

Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction [PDF]

, 2019
Pulmonary hypertension in the setting of heart failure with preserved ejection fraction (PH-HFpEF) is a growing public health problem that is increasing in prevalence.
Gladwin, Mark T., Lai, Yen‐Chun, Wang, Longfei   +2 more
core   +1 more source

Combination therapy of midodrine and droxidopa for refractory hypotension in heart failure with preserved ejection fraction per a pharmacist’s proposal: a case report

Journal of Pharmaceutical Health Care and Sciences, 2021
Background Patients with chronic heart failure (CHF) are often treated using many diuretics for symptom relief; however, diuretic use may have to continue despite hypotension development in these patients.
Yuki Asai, Tomoaki Sato, Daisuke Kito, Takanori Yamamoto, Iwao Hioki, Yasuhisa Urata, Yasuharu Abe   +6 more
doaj   +1 more source

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach

European Journal of Heart Failure
AbstractAimPathophysiological differences between patients with heart failure with preserved (HFpEF) and reduced (HFrEF) ejection fraction (EF) remain unclear. Therefore we used a phenomics approach, integrating selected proteomics data with patient characteristics and cardiac structural and functional parameters, to get insight into differential ...
Van Essen, Bart J, Tharshana, Ganash N, Ouwerkerk, Wouter, Yeo, Poh Suan Daniel, Sim, David, Jaufeerally, Fazlur, Ong, Hean Yee, Ling, Lieng Hsi, Soon, Dinna Kar Nee, Lee, Shao Guang Sheldon, Leong, Gerard, Loh, Seet Yoong, San Tan, Ru, Ramachandra, Chrishan J, Hausenloy, Derek J, Liew, Oi Wai, Chong, Jenny, Voors, Adriaan A, Lam, Carolyn SP, Richards, A Mark, Tromp, Jasper   +20 more
openaire   +4 more sources

The Treatment of Heart Failure with Reduced Ejection Fraction

Deutsches Ärzteblatt international, 2020
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.This review is based on articles retrieved by a selective search in PubMed, as well as on relevant guidelines.Evidence-based treatment options are available only for ...
Dominik, Berliner, Anja, Hänselmann, Johann, Bauersachs   +2 more
openaire   +3 more sources